Skip to main navigation Skip to search Skip to main content

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

  • Caroline Benedicte Kjærulff Mathiesen (Introductory speaker)

    Activity: Talk or presentation typesLecture or presentation

    Period29 Aug 2018
    Event titleBenzon Symposia - 2018
    Event typeConference
    Degree of RecognitionInternational